Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9444)
All Articles published online
|
Publishing Process of This Article
|
Dec 14, 2013 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Koido S, Ohkusa T, Homma S, Namiki Y, Takakura K, Saito K, Ito Z, Kobayashi H, Kajihara M, Uchiyama K, Arihiro S, Arakawa H, Okamoto M, Gong J, Tajiri H. Immunotherapy for colorectal cancer. World J Gastroenterol 2013; 19(46): 8531-8542 [PMID: 24379570 DOI: 10.3748/wjg.v19.i46.8531] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i46/8531.htm |
| Number | Citing Articles |
| 1 |
Eleni Gounari, Nikolaos Tsagias, Angelos Daniilidis, Kokkona Kouzi, George Koliakos. Αn optimized, simplified and clinically approved culture system to produce, in large scale, dendritic cells capable of priming specific T cells. Differentiation 2022; 125: 54 doi: 10.1016/j.diff.2022.05.002
|
| 2 |
Xinru You, Yang Kang, Geoffrey Hollett, Xing Chen, Wei Zhao, Zhipeng Gu, Jun Wu. Polymeric nanoparticles for colon cancer therapy: overview and perspectives. Journal of Materials Chemistry B 2016; 4(48): 7779 doi: 10.1039/C6TB01925K
|
| 3 |
Malgorzata Krzystek-Korpacka, Marek Zawadzki, Bartosz Kapturkiewicz, Paulina Lewandowska, Iwona Bednarz-Misa, Sabina Gorska, Wojciech Witkiewicz, Andrzej Gamian. Subsite heterogeneity in the profiles of circulating cytokines in colorectal cancer. Cytokine 2018; 110: 435 doi: 10.1016/j.cyto.2018.05.015
|
| 4 |
N.E. El-Ashmawy, E.A. El-Zamarany, M.L. Salem, H.A. El-Bahrawy, G.M. Al-Ashmawy. In vitro and in vivo studies of the immunomodulatory effect of Echinacea purpurea on dendritic cells. Journal of Genetic Engineering and Biotechnology 2015; 13(2): 185 doi: 10.1016/j.jgeb.2015.05.002
|
| 5 |
Hui Zhu, Xuejing Yang, Jiali Li, Yanjie Ren, Tianyu Zhang, Chunze Zhang, Jintai Zhang, Jing Li, Yan Pang. Immune Response, Safety, and Survival and Quality of Life Outcomes for Advanced Colorectal Cancer Patients Treated with Dendritic Cell Vaccine and Cytokine-Induced Killer Cell Therapy. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/603871
|
| 6 |
Vanessa Deschoolmeester, David Kerr, Patrick Pauwels, Jan B. Vermorken. Immunotherapy for Gastrointestinal Cancer. 2017; : 23 doi: 10.1007/978-3-319-43063-8_2
|
| 7 |
Haifeng Wang, Weihuo Pan. Challenges of chimeric antigen receptor-T/natural killer cell therapy in the treatment of solid tumors: focus on colorectal cancer and evaluation of combination therapies. Molecular and Cellular Biochemistry 2023; 478(5): 967 doi: 10.1007/s11010-022-04568-0
|
| 8 |
John Thomas Palathingal, Basil Sunny, Vismaya Vijayan. Combining Chemotherapy with Immunotherapy in Colorectal Cancer: A Review. Clinical Cancer Drugs 2021; 8(1): 10 doi: 10.2174/2212697X07999201029200025
|
| 9 |
Shyam S. Mohapatra, Surinder K. Batra, Srinivas Bharadwaj, Michael Bouvet, Bard Cosman, Ajay Goel, Wilma Jogunoori, Michael J. Kelley, Lopa Mishra, Bibhuti Mishra, Subhra Mohapatra, Bhaumik Patel, Joseph R. Pisegna, Jean-Pierre Raufman, Shuyun Rao, Hemant Roy, Maren Scheuner, Satish Singh, Gitanjali Vidyarthi, Jon White. Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions. Digestive Diseases and Sciences 2018; 63(5): 1123 doi: 10.1007/s10620-018-5000-0
|
| 10 |
Héctor Randhall Callata-Carhuapoma, Jesús García-Foncillas López. Textbook of Gastrointestinal Oncology. 2019; : 465 doi: 10.1007/978-3-030-18890-0_26
|
| 11 |
Shailesh Advani, Scott Kopetz. Ongoing and future directions in the management of metastatic colorectal cancer: Update on clinical trials. Journal of Surgical Oncology 2019; 119(5): 642 doi: 10.1002/jso.25441
|
| 12 |
Athanasios Patsalias, Zuzana Kozovska. Personalized medicine: Stem cells in colorectal cancer treatment. Biomedicine & Pharmacotherapy 2021; 141: 111821 doi: 10.1016/j.biopha.2021.111821
|
| 13 |
Jeremy Russell. Management of colorectal cancer patients with brain metastases. ANZ Journal of Surgery 2018; 88(3): 126 doi: 10.1111/ans.14227
|
| 14 |
Perry T. Yin, Edward Han, Ki‐Bum Lee. Engineering Stem Cells for Biomedical Applications. Advanced Healthcare Materials 2016; 5(1): 10 doi: 10.1002/adhm.201400842
|
| 15 |
Shi-Tong Wang, Wen-Qi Cui, Dan Pan, Min Jiang, Bing Chang, Li-Xuan Sang. Tea polyphenols and their chemopreventive and therapeutic effects on colorectal cancer. World Journal of Gastroenterology 2020; 26(6): 562-597 doi: 10.3748/wjg.v26.i6.562
|
| 16 |
Huichuan Yu, Yanxin Luo, Hui Peng, Liang Kang, Meijin Huang, Shuangling Luo, Wenhao Chen, Zihuan Yang, Jianping Wang. The predicting value of postoperative body temperature on long-term survival in patients with rectal cancer. Tumor Biology 2015; 36(10): 8055 doi: 10.1007/s13277-015-3535-7
|
| 17 |
Fabio Gelsomino, Monica Barbolini, Andrea Spallanzani, Giuseppe Pugliese, Stefano Cascinu. The evolving role of microsatellite instability in colorectal cancer: A review. Cancer Treatment Reviews 2016; 51: 19 doi: 10.1016/j.ctrv.2016.10.005
|
| 18 |
Jingxiu Niu, Yanjie Ren, Tianyu Zhang, Xuejing Yang, Wei Zhu, Hui Zhu, Jing Li, Jiali Li, Yan Pang. Retrospective Comparative Study of the Effects of Dendritic Cell Vaccine and Cytokine-Induced Killer Cell Immunotherapy with that of Chemotherapy Alone and in Combination for Colorectal Cancer. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/214727
|
| 19 |
Mariappan Rajan, Rajendran Amarnath Praphakar, Periyakaruppan Pradeepkumar. Polymer Nanocomposites in Biomedical Engineering. Lecture Notes in Bioengineering 2019; : 235 doi: 10.1007/978-3-030-04741-2_8
|
| 20 |
Suman K. Ray, Yamini Meshram, Sukhes Mukherjee. Cancer Immunology and CAR-T Cells: A Turning Point Therapeutic Approach in Colorectal Carcinoma with Clinical Insight. Current Molecular Medicine 2021; 21(3): 221 doi: 10.2174/1566524020666200824103749
|
| 21 |
E. Bohlul, F. Hasanlou, A.H. Taromchi, S. Nadri. TRAIL‐expressing recombinantLactococcus lactisinduces apoptosis in human colon adenocarcinomaSW480 andHCT116 cells. Journal of Applied Microbiology 2019; 126(5): 1558 doi: 10.1111/jam.14237
|
| 22 |
Ahmed Gamal, Mohammed Elshaer, Mayyadah Alabdely, Ahmed Kadry, Thomas S. McCormick, Mahmoud Ghannoum. The Mycobiome: Cancer Pathogenesis, Diagnosis, and Therapy. Cancers 2022; 14(12): 2875 doi: 10.3390/cancers14122875
|
| 23 |
Hamid Motamedi, Marzie Mahdizade Ari, Mohsen Shahlaei, Sajad Moradi, Parisa Farhadikia, Amirhoushang Alvandi, Ramin Abiri. Designing multi-epitope vaccine against important colorectal cancer (CRC) associated pathogens based on immunoinformatics approach. BMC Bioinformatics 2023; 24(1) doi: 10.1186/s12859-023-05197-0
|
| 24 |
Malgorzata Krzystek-Korpacka, Marek Zawadzki, Katarzyna Neubauer, Iwona Bednarz-Misa, Sabina Górska, Jerzy Wiśniewski, Wojciech Witkiewicz, Andrzej Gamian. Elevated systemic interleukin-7 in patients with colorectal cancer and individuals at high risk of cancer: association with lymph node involvement and tumor location in the right colon. Cancer Immunology, Immunotherapy 2017; 66(2): 171 doi: 10.1007/s00262-016-1933-3
|
| 25 |
Mamdooh H Ghoneum, Takeshi Ogura, James K Gimzewski, Aya D Ghoneum, Michael C Henary, Sudhanshu Agrawal. Marina crystal minerals (MCM) activate human dendritic cells to induce CD4+ and CD8+ T cell responses in vitro. International Journal of Immunopathology and Pharmacology 2018; 32: 205873841879776 doi: 10.1177/2058738418797768
|
| 26 |
Joanne Ern Chi Soh, Nadiah Abu, Rahman Jamal. The potential immune-eliciting cancer testis antigens in colorectal cancer. Immunotherapy 2018; 10(12): 1093 doi: 10.2217/imt-2018-0044
|
| 27 |
Anvay Ukidve, Katharina Cu, Ninad Kumbhojkar, Joerg Lahann, Samir Mitragotri. Overcoming biological barriers to improve solid tumor immunotherapy. Drug Delivery and Translational Research 2021; 11(6): 2276 doi: 10.1007/s13346-021-00923-8
|
| 28 |
Mikio Kajihara, Kazuki Takakura, Tomoya Kanai, Zensho Ito, Keisuke Saito, Shinichiro Takami, Shigetaka Shimodaira, Masato Okamoto, Toshifumi Ohkusa, Shigeo Koido. Dendritic cell-based cancer immunotherapy for colorectal cancer. World Journal of Gastroenterology 2016; 22(17): 4275-4286 doi: 10.3748/wjg.v22.i17.4275
|
| 29 |
Scott A Fisher, Amanda Cleaver, Devina D Lakhiani, Andrea Khong, Theresa Connor, Ben Wylie, W Joost Lesterhuis, Bruce WS Robinson, Richard A Lake. Neoadjuvant anti-tumor vaccination prior to surgery enhances survival. Journal of Translational Medicine 2014; 12(1) doi: 10.1186/s12967-014-0245-7
|
| 30 |
Mamdooh H Ghoneum, James K Gimzewski, Aya D Ghoneum, Sudhanshu Agrawal. Potential role of MRN-100, an iron-based compound, in upregulating production of cytokine IL-10 in human dendritic cells to promote an anti-inflammatory response in vitro. International Journal of Immunopathology and Pharmacology 2019; 33: 205873841984493 doi: 10.1177/2058738419844932
|
| 31 |
G.V. Seledtsova, A.A. Shishkov, E.A. Kaschenko, V.I. Seledtsov. Xenogeneic cell-based vaccine therapy for colorectal cancer: Safety, association of clinical effects with vaccine-induced immune responses. Biomedicine & Pharmacotherapy 2016; 83: 1247 doi: 10.1016/j.biopha.2016.08.050
|
| 32 |
Elisabetta Radice, Graziella Bellone, Vincenzo Miranda. Enhancement of the Immunostimulatory Functions of Ex Vivo–Generated Dendritic Cells from Early-Stage Colon Cancer Patients by Consecutive Exposure to Low Doses of Sequential-Kinetic-Activated IL-4 and IL-12. A Preliminary Study. Translational Oncology 2015; 8(4): 327 doi: 10.1016/j.tranon.2015.06.005
|
| 33 |
Iris N. Pardieck, Priscilla A. Jawahier, Marloes Swets, Cornelis J.H. van de Velde, Peter J.K. Kuppen. Novel avenues in immunotherapies for colorectal cancer. Expert Review of Gastroenterology & Hepatology 2016; 10(4): 465 doi: 10.1586/17474124.2016.1122522
|
| 34 |
Mei Zhang, Julian A. Kim, Alex Yee-Chen Huang. Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based Nanoparticles. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00341
|
| 35 |
Xiaolong Wang, Liang Chen, Hongtao Cao, Jianpeng Huang, Xing Huang. Identification of Gene Signature-Related Oxidative Stress for Predicting Prognosis of Colorectal Cancer. Oxidative Medicine and Cellular Longevity 2023; 2023: 1 doi: 10.1155/2023/5385742
|
| 36 |
Xin Qiao, Wei Sun, Chongzhi Wang, Li Zhang, Ping Li, Xiaodong Wen, Jie Yang, Chunsu Yuan. Polyyne-Enriched Extract from Oplopanax elatus Significantly Ameliorates the Progression of Colon Carcinogenesis in ApcMin/+ Mice. Molecules 2017; 22(10): 1593 doi: 10.3390/molecules22101593
|
| 37 |
Pawel Kalinski, James E. Talmadge. Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy. Advances in Experimental Medicine and Biology 2017; 1036: 1 doi: 10.1007/978-3-319-67577-0_1
|
| 38 |
Jianxiu Lin, Yang Ran, Tengfei Wu, Zishan Wang, Jinjin Zhao, Yun Tian. A New Method for Constructing Macrophage-Associated Predictors of Treatment Efficacy Based on Single-Cell Sequencing Analysis. Journal of Immunotherapy 2024; 47(2): 33 doi: 10.1097/CJI.0000000000000497
|
| 39 |
Daniel Sur, Andrei Havasi, Calin Cainap, Gabriel Samasca, Claudia Burz, Ovidiu Balacescu, Iulia Lupan, Diana Deleanu, Alexandru Irimie. Chimeric Antigen Receptor T-Cell Therapy for Colorectal Cancer. Journal of Clinical Medicine 2020; 9(1): 182 doi: 10.3390/jcm9010182
|
| 40 |
Aline Van Acker, Els Louagie, Jessica Filtjens, Sylvie Taveirne, Els Van Ammel, Tessa Kerre, Dirk Elewaut, Tom Taghon, Bart Vandekerckhove, Jean Plum, Georges Leclercq. The role of Ly49E receptor expression on murine intraepithelial lymphocytes in intestinal cancer development and progression. Cancer Immunology, Immunotherapy 2016; 65(11): 1365 doi: 10.1007/s00262-016-1894-6
|
| 41 |
Fatemeh K. Dermani, Pouria Samadi, Golebagh Rahmani, Alisa K. Kohlan, Rezvan Najafi. PD‐1/PD‐L1 immune checkpoint: Potential target for cancer therapy. Journal of Cellular Physiology 2019; 234(2): 1313 doi: 10.1002/jcp.27172
|
| 42 |
José Alexandre Ferreira, Ana Magalhães, Joana Gomes, Andreia Peixoto, Cristiana Gaiteiro, Elisabete Fernandes, Lúcio Lara Santos, Celso A. Reis. Protein glycosylation in gastric and colorectal cancers: Toward cancer detection and targeted therapeutics. Cancer Letters 2017; 387: 32 doi: 10.1016/j.canlet.2016.01.044
|
| 43 |
Ana I. Matos, Barbara Carreira, Carina Peres, Liane I.F. Moura, João Conniot, Thibaut Fourniols, Anna Scomparin, Águeda Martínez-Barriocanal, Diego Arango, João P. Conde, Véronique Préat, Ronit Satchi-Fainaro, Helena F. Florindo. Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer. Journal of Controlled Release 2019; 307: 108 doi: 10.1016/j.jconrel.2019.06.017
|
| 44 |
Yufu Lin, Yabo Chen, Lu Gan, Zhiyong Li, Feng Shen. A prognostic model based on tumor microenvironment and immune cell in colorectal cancer. Scandinavian Journal of Gastroenterology 2024; 59(3): 304 doi: 10.1080/00365521.2023.2281252
|
| 45 |
Helge Bruns, Darius Kazanavicius, Daniel Schultze, Mohammed Al Saeedi, Kenia Yamanaka, Kestutis Strupas, Peter Schemmer. Glycine inhibits angiogenesis in colorectal cancer: role of endothelial cells. Amino Acids 2016; 48(11): 2549 doi: 10.1007/s00726-016-2278-0
|
| 46 |
Itzel Medina-Andrade, Jonadab E. Olguín, Tonathiu Rodríguez, Luis I. Terrazas. Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives. 2021; : 103 doi: 10.1016/B978-0-12-822028-3.00003-0
|
| 47 |
Shiro Kibe, Shigeru Yutani, Satoru Motoyama, Takanobu Nomura, Natsuki Tanaka, Akihiko Kawahara, Tomohiko Yamaguchi, Satoko Matsueda, Nobukazu Komatsu, Masatomo Miura, Yudai Hinai, Satoshi Hattori, Akira Yamada, Masayoshi Kage, Kyogo Itoh, Yoshito Akagi, Tetsuro Sasada. Phase II Study of Personalized Peptide Vaccination for Previously Treated Advanced Colorectal Cancer. Cancer Immunology Research 2014; 2(12): 1154 doi: 10.1158/2326-6066.CIR-14-0035
|
| 48 |
Walid Shaib, Daniel Goldstein, Bassel F. El-Rayes. Peptide Vaccines for Treatment of Colon Cancer: Have We Made Progress?. Current Colorectal Cancer Reports 2014; 10(4): 477 doi: 10.1007/s11888-014-0250-5
|
| 49 |
Abhijit Sasmal, Deeparani Urolagin. Immunomodulatory activity of Cestrum nocturnum. - A Comprehensive review. Asian Journal of Pharmacy and Technology 2022; : 33 doi: 10.52711/2231-5713.2022.00006
|
| 50 |
Shigetaka Shimodaira, Kenji Sano, Koichi Hirabayashi, Terutsugu Koya, Yumiko Higuchi, Yumiko Mizuno, Naoko Yamaoka, Miki Yuzawa, Takashi Kobayashi, Kenichi Ito, Tomonobu Koizumi. Dendritic Cell-Based Adjuvant Vaccination Targeting Wilms’ Tumor 1 in Patients with Advanced Colorectal Cancer. Vaccines 2015; 3(4): 1004 doi: 10.3390/vaccines3041004
|
| 51 |
Magdalena Szaryńska, Agata Olejniczak, Jarosław Kobiela, Dariusz Łaski, Zbigniew Śledziński, Zbigniew Kmieć. Cancer stem cells as targets for DC-based immunotherapy of colorectal cancer. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-30525-3
|
| 52 |
Paula Mosińska, Agata Gabryelska, Malwina Zasada, Jakub Fichna. Dual Functional Capability of Dendritic Cells – Cytokine-Induced Killer Cells in Improving Side Effects of Colorectal Cancer Therapy. Frontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00126
|
| 53 |
Marta Kaleta-Richter, Aleksandra Kawczyk-Krupka, David Aebisher, Dorota Bartusik-Aebisher, Zenon Czuba, Grzegorz Cieślar. The capability and potential of new forms of personalized colon cancer treatment: Immunotherapy and Photodynamic Therapy. Photodiagnosis and Photodynamic Therapy 2019; 25: 253 doi: 10.1016/j.pdpdt.2019.01.004
|
| 54 |
Nur Aqlili Riana Alias, Winfrey Pui Yee Hoo, Pui Yan Siak, Siti Sarah Othman, Noorjahan Banu Mohammed Alitheen, Lionel Lian Aun In, Raha Abdul Rahim, Adelene Ai-Lian Song. Effect of Secretion Efficiency of Mutant KRAS Neoantigen by Lactococcus lactis on the Immune Response of a Mucosal Vaccine Delivery Vehicle Targeting Colorectal Cancer. International Journal of Molecular Sciences 2023; 24(10): 8928 doi: 10.3390/ijms24108928
|
| 55 |
Pooneh Mokarram, Mohammed Albokashy, Maryam Zarghooni, Mohammad Amin Moosavi, Zahra Sepehri, Qi Min Chen, Andrzej Hudecki, Aliyeh Sargazi, Javad Alizadeh, Adel Rezaei Moghadam, Mohammad Hashemi, Hesam Movassagh, Thomas Klonisch, Ali Akbar Owji, Marek J. Łos, Saeid Ghavami. New frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targets. Autophagy 2017; 13(5): 781 doi: 10.1080/15548627.2017.1290751
|
| 56 |
Esmeralda Celia Marginean, Barbara Melosky. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part II—The Challenge of Programmed Death Ligand-1 Testing and Its Role in Microsatellite Instability-High Colorectal Cancer. Archives of Pathology & Laboratory Medicine 2018; 142(1): 26 doi: 10.5858/arpa.2017-0041-RA
|
| 57 |
Pawel Kalinski, Per Basse. Immune Checkpoint Inhibitors in Cancer. 2019; : 1 doi: 10.1016/B978-0-323-54948-6.00001-9
|
| 58 |
Manik Amin, Albert Craig Lockhart. The potential role of immunotherapy to treat colorectal cancer. Expert Opinion on Investigational Drugs 2015; 24(3): 329 doi: 10.1517/13543784.2015.985376
|
| 59 |
Sameh H. Emile, Nir Horesh, Michael R. Freund, Zoe Garoufalia, Rachel Gefen, Emanuela Silva-Alvarenga, David J. Maron, Giovanna DaSilva, Steven D. Wexner. Trends in the Characteristics, Treatment, and Outcomes of Rectal Adenocarcinoma in the US From 2004 to 2019. JAMA Oncology 2023; 9(3): 355 doi: 10.1001/jamaoncol.2022.6116
|
| 60 |
Se Hee Park, Kon-Young Ji, Hyun Min Kim, Sang Hoon Ma, Seo Young Park, Ju Hui Do, Doo-Byoung Oh, Hyung Sik Kang, Jae Sung Shim, Young Hee Joung. Optimization of the human colorectal carcinoma antigen GA733-2 production in tobacco plants. Plant Biotechnology Reports 2021; 15(1): 55 doi: 10.1007/s11816-020-00657-y
|
| 61 |
Carrie Snyder. Evolution of cancer risk assessment and counseling related to psychological, financial and legal implications. Familial Cancer 2016; 15(3): 493 doi: 10.1007/s10689-016-9890-8
|
| 62 |
Noam Auslander, Yuri I. Wolf, Eugene V. Koonin. Interplay between DNA damage repair and apoptosis shapes cancer evolution through aneuploidy and microsatellite instability. Nature Communications 2020; 11(1) doi: 10.1038/s41467-020-15094-2
|
| 63 |
Shigetaka Shimodaira, Koichi Hirabayashi, Ryu Yanagisawa, Yumiko Higuchi, Kenji Sano, Tomonobu Koizumi. Wilms Tumor. 2016; : 113 doi: 10.15586/codon.wt.2016.ch8
|
| 64 |
Nicola Flaum, Paul Lorigan, Gillian A. Whitfield, Robert E. Hawkins, Mark B. Pinkham. Integrating radiation therapy with emerging systemic therapies: Lessons from a patient with cerebral radionecrosis, spinal cord myelopathy, and radiation pneumonitis. Practical Radiation Oncology 2016; 6(2): 110 doi: 10.1016/j.prro.2015.10.008
|
| 65 |
Young-Eun Kim, Sanghoon Kwon, Guang Wu, Dongbum Kim, Byoung Kwon Park, Jeong-A Park, Kyung-Chan Choi, Doo-Sik Kim, Hyung-Joo Kwon, Younghee Lee. Therapeutic effect of a TM4SF5-specific monoclonal antibody against colon cancer in a mouse model. Oncotarget 2014; 5(18): 8402 doi: 10.18632/oncotarget.2311
|
| 66 |
Mikio Kajihara, Kazuki Takakura, Tomoya Kanai, Zensho Ito, Yoshihiro Matsumoto, Shigetaka Shimodaira, Masato Okamoto, Toshifumi Ohkusa, Shigeo Koido. Advances in inducing adaptive immunity using cell-based cancer vaccines: Clinical applications in pancreatic cancer. World Journal of Gastroenterology 2016; 22(18): 4446-4458 doi: 10.3748/wjg.v22.i18.4446
|
| 67 |
Huanyu Ju, Wenjing Xing, Jinfeng Yang, Yang Zheng, Xiuzhi Jia, Benning Zhang, Huan Ren. An effective cytokine adjuvant vaccine induces autologous T-cell response against colon cancer in an animal model. BMC Immunology 2016; 17(1) doi: 10.1186/s12865-016-0172-x
|